Attitude of Health PersonnelChlamydia InfectionsChlamydia trachomatis
Dr. Paul D. Richards, MD
NPI1053387266
- Medicare services, 2023
- 357
- Part D claims, 2024
- 94
- Publications
- 43
- Clinical trials
- 10
- MIPS score, 2024
- 85
- Practice address
- 2013 Jefferson SW St, Roanoke, VA 24014
- Practice phone
- Call (540) 982-0237
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Blue Ridge Cancer Care
Roanoke, Virginia
Find Dr. Richards' professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Paul D. Richards is a hematologist and oncologist in Roanoke, Virginia
Dr. Richards practices at Blue Ridge Cancer Care in Roanoke, Virginia.
Dr. Richards' NPI, 1053387266, was assigned on February 27, 2006. Dr. Richards graduated from Tulane University School of Medicine in 1979. Dr. Richards holds Virginia license 0101038197.
NPI and contact details
- NPI
- 1053387266NPI Registry (opens in a new tab)
- NPI enumeration date
- February 27, 2006
- NPI status
- Active
- Practice phone
- (540) 982-0237
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 73
- Medical school graduation
- 1979
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Practice Data
Dr. Paul D. Richards practices at Blue Ridge Cancer Care in Roanoke, Virginia
Dr. Richards' primary practice is Blue Ridge Cancer Care, at 2013 Jefferson SW St, Roanoke, VA 24014 in Roanoke City. The practice phone is (540) 982-0237.
- Blue Ridge Cancer Care2013 Jefferson SW St, Roanoke, VA 24014 · Roanoke CityPhone(540) 982-0237
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Paul D. Richards is affiliated with 2 sites of care and 1 medical group
Dr. Richards' primary practice is Blue Ridge Cancer Care in Roanoke, Virginia. Dr. Richards is also affiliated with LewisGale Medical Center. The medical group on file is Blue Ridge Cancer Care.
Blue Ridge Cancer CarePrimary
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Paul D. Richards' practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Richards practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Blue Ridge Cancer Care | Available with a free account |
| +1 more affiliated site | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Richards practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Paul D. Richards is one of 297 hematologists and oncologists in Virginia
Hematology and oncology is Dr. Richards' primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Richards is licensed in Virginia.
Specialties and state licenses
- Hematology and oncology, VirginiaPrimary
Hematologists and oncologists near Dr. Richards
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Paul D. Richards billed Medicare for 357 services in 2023
CMS data shows 357 Medicare services from Dr. Richards across 12 procedure codes in 2023. Medicare paid $14,542 for them. Every service was in an office.
Medicare services, 2023357
Paid by Medicare$14,542
Procedure codes12
Dr. Richards' Medicare services by type, 2022 to 2023
- 2022
- 2023
- Lab and pathology
- 2022: 3,9332023: 18095%
- Office and hospital visits
- 2022: 1,0952023: 13987%
- Surgery
- 2022: 6002023: 3894%
- Drugs given in the office
- 2022: 60,5012023: 0100%
- Tests and treatments
- 2022: 1,4662023: 0100%
- Other services
- 2022: 1,9632023: 0100%
Dr. Richards compared with the Virginia median for hematologists and oncologists, 2023
- Dr. Richards
- Virginia median
- Medicare services
- 357vs 3,51490% below
- Part D claims
- 28vs 45294% below
Medians across 275 hematologists and oncologists in Virginia with Dmand AI profiles that report each measure.
Dr. Richards' most billed Medicare procedure codes, 2023
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Richards?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Richards and other hematologists and oncologists in Virginia.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Paul D. Richards' patients have a median age of 75
Across all payers, Dmand AI patient panel data puts Dr. Richards' median patient age at 75, with 71% women.
Dr. Richards' patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 75
Patient panel by sex, all payers
- Women71%
- Men29%
Source: Dmand AI Patient Panel Data
Dr. Paul D. Richards wrote 94 Medicare Part D claims in 2024
In 2024, Dr. Richards wrote 94 Medicare Part D claims for 40 patients. 79% of them were for generic drugs. CMS names the drug for 28 of them, across 2 drugs with 11 or more claims each, at $540 in total drug cost. In 2023, CMS named 194 claims across 9 drugs.
Part D claims, 202494
Drugs named by CMS2
Total drug cost$540
Part D patients40
Dr. Richards' Part D claims by kind of drug, 2024
- Generic74 claims79%
- Brand-name20 claims21%
Dr. Richards' most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 1942024: 2886%
Drugs named by CMS: 2 in 2024, 9 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Paul D. Richards scored 85 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Richards for performance year 2024, reported as part of a group.
Dr. Richards' MIPS scores, performance year 2024
- 85of 100Final score
- 70.3of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
- 68of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Source: Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Find hematologists and oncologists like Dr. Richards by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Paul D. Richards has 43 publications on record
Dmand AI links 43 papers to Dr. Richards, published from 2012 to 2025. 2017 was the busiest year, with 6. The most frequent topics are Breast Neoplasms, HIV Infections and Pre-Exposure Prophylaxis. Dr. Richards has published most often in Ann Surg Oncol. Dr. Richards' most frequent co-authors are Jason E. Zucker, MD, Alwyn Cohall, MD and Magdalena Elzbieta Sobieszczyk, MD.
Papers43
Years published2012 to 2025
Dr. Richards' papers by year, 2016 to 2025
Topics Dr. Richards writes about most
- Breast Neoplasms
- HIV Infections
- Pre-Exposure Prophylaxis
- Antineoplastic Combined Chemotherapy Protocols
- Glucagon-Like Peptide 1
- Receptor, ErbB-2
- Anti-HIV Agents
- Antineoplastic Agents, Hormonal
Dr. Richards' most frequent co-authors
- Jason E. Zucker, MD8 shared papers
- Alwyn Cohall, MD7 shared papers
- Magdalena Elzbieta Sobieszczyk, MD7 shared papers
Recent publications by Dr. Richards
Adenylate KinaseBiological TransportGrowth Differentiation Factor 15
HIV InfectionsNew York CityPatient Preference
Administration, OralBiopsyCyclin-Dependent Kinase Inhibitor Proteins
See who Dr. Richards researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Richards works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Paul D. Richards has worked on 10 clinical trials
Dmand AI links Dr. Richards to 10 clinical trials, 2 of them phase 2 studies. 6 are still active or recruiting. Conditions studied include Breast Neoplasms, Breast Diseases and Endometrial Neoplasms. Eli Lilly and Company sponsors the most, 5. Open Payments lists research payments to Dr. Richards that name 4 trials.
Clinical trials with Dr. Richards by phase
- 1Phase 1: 1 trial
- 1Phase 1/2: 1 trial
- 2Phase 2: 2 trials
- NonePhase 3: no trials
- NonePhase 4: no trials
Conditions in Dr. Richards' trials
- Breast Neoplasms
- Breast Diseases
- Endometrial Neoplasms
- Lymphoma, T-Cell, Peripheral
- Uterine Cervical Neoplasms
Investigators on the most trials with Dr. Richards
- Margaret Block, MD5 shared trials
- Erika P. Hamilton, MD5 shared trials
- Jay Christopher Andersen, MD4 shared trials
Recent clinical trials with Dr. Richards
A Phase 1b/2, First-in-Human, Dose Escalation and Expansion Study of XMT-1536 In Patients With Solid Tumors Likely to Express NaPi2b (opens in a new tab)
Active, not recruitingPhase 1/2
Upifitamab rilsodotin
A Study of Tucatinib Plus Trastuzumab Deruxtecan in HER2+ Breast Cancer (opens in a new tab)
Active, not recruitingPhase 2
Breast NeoplasmsBreast DiseasesTrastuzumab deruxtecanTucatinib
Lymphoma, T-Cell, PeripheralUterine Cervical NeoplasmsSEA-TGTBrentuximab vedotinSasanlimab
Adjuvant Ribociclib With Endocrine Therapy in Hormone Receptor+/HER2- High Risk Early Breast Cancer (opens in a new tab)
CompletedPhase 2
Breast NeoplasmsBreast DiseasesRibociclibAdjuvant endocrine therapy
A Study of Abemaciclib (LY2835219) Combined With Fulvestrant in Women With Hormone Receptor Positive HER2 Negative Breast Cancer (opens in a new tab)
Active, not recruiting
$2,727 in research paymentsBreast NeoplasmsBreast DiseasesAbemaciclibFulvestrant
Sources: Open Payments (CMS), 2025 data, released July 7, 2026; Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Paul D. Richards received $19,299 in industry payments from 2016 to 2023
CMS Open Payments shows 84 general payments to Dr. Richards from 28 drug and device companies from 2016 to 2023. Consulting fees make up the largest share, 64% of the total. Celgene Corporation paid the most, $6,879. It also lists 9 research payments totaling $17,555 from 2017 to 2021, naming 4 clinical trials.
General payments to Dr. Richards by program year, 2016 to 2023
General payments to Dr. Richards by kind, 2016 to 2023
$19.3Kin total
- Consulting fees$12,28064%
- Travel and lodging$4,04621%
- Food and beverage$2,65814%
- Education$3162%
Companies that paid Dr. Richards the most, 2016 to 2023
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Paul D. Richards graduated from Tulane University School of Medicine
Dr. Richards graduated from Tulane University School of Medicine in 1979.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Paul D. Richards's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Paul D. Richards
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Paul D. Richards' NPI number?
Dr. Paul D. Richards' NPI number is 1053387266. It was assigned on February 27, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Paul D. Richards?
Dr. Paul D. Richards is a hematologist and oncologist in Roanoke, Virginia. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Paul D. Richards practice?
Dr. Richards practices at 2013 Jefferson SW St, Roanoke, VA 24014. Dr. Richards' primary practice is Blue Ridge Cancer Care in Roanoke, Virginia.
What is Dr. Paul D. Richards' office phone number?
The practice phone on file for Dr. Richards is (540) 982-0237.
What is Dr. Paul D. Richards' medical license number?
Dr. Richards holds Virginia license 0101038197.
Which hospitals is Dr. Paul D. Richards affiliated with?
Dr. Richards is affiliated with LewisGale Medical Center.
What medical group is Dr. Paul D. Richards part of?
Dr. Richards is linked to Blue Ridge Cancer Care.
Does Dr. Paul D. Richards accept Medicare?
Yes. CMS data shows Dr. Richards billed Medicare for 357 services in 2023.
What is Dr. Paul D. Richards' MIPS score?
Dr. Richards' MIPS final score for performance year 2024 is 85 out of 100, reported as part of a group.
What services does Dr. Paul D. Richards bill to Medicare?
In 2023, Dr. Richards' most billed Medicare services were lab and pathology test (85025), office visit, established patient (99213) and lab and pathology test (80053).
Show 6 more questionsShow fewer questions
Where did Dr. Paul D. Richards go to medical school?
Dr. Richards graduated from Tulane University School of Medicine in 1979.
What drugs does Dr. Paul D. Richards prescribe most?
In 2024 Medicare Part D data, Dr. Richards' most prescribed drugs by claims were Letrozole and Famotidine.
Has Dr. Paul D. Richards received payments from drug or device companies?
CMS Open Payments shows $19,299 in general payments to Dr. Richards from 28 companies from 2016 to 2023. The largest total came from Celgene Corporation.
How long has Dr. Paul D. Richards been practicing?
Dr. Richards graduated from medical school in 1979, 47 years ago.
Does Dr. Paul D. Richards do research?
Dmand AI links 43 publications to Dr. Richards, published from 2012 to 2025. Dr. Richards has worked on 10 clinical trials.
Who does Dr. Paul D. Richards publish with?
Dr. Richards' most frequent co-authors are Jason E. Zucker, MD (8 shared papers), Alwyn Cohall, MD (7 shared papers) and Magdalena Elzbieta Sobieszczyk, MD (7 shared papers).
Selling to hematology and oncology practices?
See hematologists and oncologists in Virginia by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card